Abstract
Treatment of paroxysmal atrial fibrillation with flecainide acetate resulted in a 4-fold increase in ventricular capture thresholds. The detailed time course of the threshold increase and decrease was documented using the AutoCapture algorithm and graphic summary.
MeSH terms
-
Aged
-
Anti-Arrhythmia Agents / adverse effects*
-
Anti-Arrhythmia Agents / therapeutic use
-
Atrial Fibrillation / physiopathology
-
Atrial Fibrillation / therapy*
-
Equipment Failure
-
Flecainide / adverse effects*
-
Flecainide / therapeutic use
-
Heart Ventricles / physiopathology*
-
Humans
-
Male
-
Pacemaker, Artificial*
Substances
-
Anti-Arrhythmia Agents
-
Flecainide